Parkinson's disease

From synaptic loss to connectome dysfunction

Arianna Bellucci, Nicola Biagio Mercuri, Annalena Venneri, Gaia Faustini, Francesca Longhena, Marina Pizzi, C. Missale, Pier Franco Spano

Research output: Contribution to journalArticle

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder with prominent loss of nigro-striatal dopaminergic neurons. The resultant dopamine (DA) deficiency underlies the onset of typical motor symptoms (MS). Nonetheless, individuals affected by PD usually show a plethora of nonmotor symptoms (NMS), part of which may precede the onset of motor signs. Besides DA neuron degeneration, a key neuropathological alteration in the PD brain is Lewy pathology. This is characterized by abnormal intraneuronal (Lewy bodies) and intraneuritic (Lewy neurites) deposits of fibrillary aggregates mainly composed of α-synuclein. Lewy pathology has been hypothesized to progress in a stereotypical pattern over the course of PD and α-synuclein mutations and multiplications have been found to cause monogenic forms of the disease, thus raising the question as to whether this protein is pathogenic in this disorder. Findings showing that the majority of α-synuclein aggregates in PD are located at presynapses and this underlies the onset of synaptic and axonal degeneration, coupled to the fact that functional connectivity changes correlate with disease progression, strengthen this idea. Indeed, by altering the proper action of key molecules involved in the control of neurotransmitter release and re-cycling as well as synaptic and structural plasticity, α-synuclein deposition may crucially impair axonal trafficking, resulting in a series of noxious events, whose pressure may inevitably degenerate into neuronal damage and death. Here, we provide a timely overview of the molecular features of synaptic loss in PD and disclose their possible translation into clinical symptoms through functional disconnection.

Original languageEnglish
Pages (from-to)77-94
Number of pages18
JournalNeuropathology and Applied Neurobiology
Volume42
Issue number1
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Connectome
Synucleins
Parkinson Disease
Dopaminergic Neurons
Pathology
Lewy Bodies
Corpus Striatum
Nerve Degeneration
Neuronal Plasticity
Neurites
Neurodegenerative Diseases
Neurotransmitter Agents
Disease Progression
Dopamine
Pressure
Mutation
Brain

Keywords

  • Axonal damage
  • Functional connectome
  • Parkinson's disease
  • Synaptic loss
  • α-synuclein

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Neurology
  • Histology
  • Physiology (medical)

Cite this

Bellucci, A., Mercuri, N. B., Venneri, A., Faustini, G., Longhena, F., Pizzi, M., ... Spano, P. F. (2016). Parkinson's disease: From synaptic loss to connectome dysfunction. Neuropathology and Applied Neurobiology, 42(1), 77-94. https://doi.org/10.1111/nan.12297

Parkinson's disease : From synaptic loss to connectome dysfunction. / Bellucci, Arianna; Mercuri, Nicola Biagio; Venneri, Annalena; Faustini, Gaia; Longhena, Francesca; Pizzi, Marina; Missale, C.; Spano, Pier Franco.

In: Neuropathology and Applied Neurobiology, Vol. 42, No. 1, 01.02.2016, p. 77-94.

Research output: Contribution to journalArticle

Bellucci, A, Mercuri, NB, Venneri, A, Faustini, G, Longhena, F, Pizzi, M, Missale, C & Spano, PF 2016, 'Parkinson's disease: From synaptic loss to connectome dysfunction', Neuropathology and Applied Neurobiology, vol. 42, no. 1, pp. 77-94. https://doi.org/10.1111/nan.12297
Bellucci, Arianna ; Mercuri, Nicola Biagio ; Venneri, Annalena ; Faustini, Gaia ; Longhena, Francesca ; Pizzi, Marina ; Missale, C. ; Spano, Pier Franco. / Parkinson's disease : From synaptic loss to connectome dysfunction. In: Neuropathology and Applied Neurobiology. 2016 ; Vol. 42, No. 1. pp. 77-94.
@article{8684c0d4fe5f4f659907241d8a16fb27,
title = "Parkinson's disease: From synaptic loss to connectome dysfunction",
abstract = "Parkinson's disease (PD) is a common neurodegenerative disorder with prominent loss of nigro-striatal dopaminergic neurons. The resultant dopamine (DA) deficiency underlies the onset of typical motor symptoms (MS). Nonetheless, individuals affected by PD usually show a plethora of nonmotor symptoms (NMS), part of which may precede the onset of motor signs. Besides DA neuron degeneration, a key neuropathological alteration in the PD brain is Lewy pathology. This is characterized by abnormal intraneuronal (Lewy bodies) and intraneuritic (Lewy neurites) deposits of fibrillary aggregates mainly composed of α-synuclein. Lewy pathology has been hypothesized to progress in a stereotypical pattern over the course of PD and α-synuclein mutations and multiplications have been found to cause monogenic forms of the disease, thus raising the question as to whether this protein is pathogenic in this disorder. Findings showing that the majority of α-synuclein aggregates in PD are located at presynapses and this underlies the onset of synaptic and axonal degeneration, coupled to the fact that functional connectivity changes correlate with disease progression, strengthen this idea. Indeed, by altering the proper action of key molecules involved in the control of neurotransmitter release and re-cycling as well as synaptic and structural plasticity, α-synuclein deposition may crucially impair axonal trafficking, resulting in a series of noxious events, whose pressure may inevitably degenerate into neuronal damage and death. Here, we provide a timely overview of the molecular features of synaptic loss in PD and disclose their possible translation into clinical symptoms through functional disconnection.",
keywords = "Axonal damage, Functional connectome, Parkinson's disease, Synaptic loss, α-synuclein",
author = "Arianna Bellucci and Mercuri, {Nicola Biagio} and Annalena Venneri and Gaia Faustini and Francesca Longhena and Marina Pizzi and C. Missale and Spano, {Pier Franco}",
year = "2016",
month = "2",
day = "1",
doi = "10.1111/nan.12297",
language = "English",
volume = "42",
pages = "77--94",
journal = "Neuropathology and Applied Neurobiology",
issn = "0305-1846",
publisher = "Wiley Blackwell",
number = "1",

}

TY - JOUR

T1 - Parkinson's disease

T2 - From synaptic loss to connectome dysfunction

AU - Bellucci, Arianna

AU - Mercuri, Nicola Biagio

AU - Venneri, Annalena

AU - Faustini, Gaia

AU - Longhena, Francesca

AU - Pizzi, Marina

AU - Missale, C.

AU - Spano, Pier Franco

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Parkinson's disease (PD) is a common neurodegenerative disorder with prominent loss of nigro-striatal dopaminergic neurons. The resultant dopamine (DA) deficiency underlies the onset of typical motor symptoms (MS). Nonetheless, individuals affected by PD usually show a plethora of nonmotor symptoms (NMS), part of which may precede the onset of motor signs. Besides DA neuron degeneration, a key neuropathological alteration in the PD brain is Lewy pathology. This is characterized by abnormal intraneuronal (Lewy bodies) and intraneuritic (Lewy neurites) deposits of fibrillary aggregates mainly composed of α-synuclein. Lewy pathology has been hypothesized to progress in a stereotypical pattern over the course of PD and α-synuclein mutations and multiplications have been found to cause monogenic forms of the disease, thus raising the question as to whether this protein is pathogenic in this disorder. Findings showing that the majority of α-synuclein aggregates in PD are located at presynapses and this underlies the onset of synaptic and axonal degeneration, coupled to the fact that functional connectivity changes correlate with disease progression, strengthen this idea. Indeed, by altering the proper action of key molecules involved in the control of neurotransmitter release and re-cycling as well as synaptic and structural plasticity, α-synuclein deposition may crucially impair axonal trafficking, resulting in a series of noxious events, whose pressure may inevitably degenerate into neuronal damage and death. Here, we provide a timely overview of the molecular features of synaptic loss in PD and disclose their possible translation into clinical symptoms through functional disconnection.

AB - Parkinson's disease (PD) is a common neurodegenerative disorder with prominent loss of nigro-striatal dopaminergic neurons. The resultant dopamine (DA) deficiency underlies the onset of typical motor symptoms (MS). Nonetheless, individuals affected by PD usually show a plethora of nonmotor symptoms (NMS), part of which may precede the onset of motor signs. Besides DA neuron degeneration, a key neuropathological alteration in the PD brain is Lewy pathology. This is characterized by abnormal intraneuronal (Lewy bodies) and intraneuritic (Lewy neurites) deposits of fibrillary aggregates mainly composed of α-synuclein. Lewy pathology has been hypothesized to progress in a stereotypical pattern over the course of PD and α-synuclein mutations and multiplications have been found to cause monogenic forms of the disease, thus raising the question as to whether this protein is pathogenic in this disorder. Findings showing that the majority of α-synuclein aggregates in PD are located at presynapses and this underlies the onset of synaptic and axonal degeneration, coupled to the fact that functional connectivity changes correlate with disease progression, strengthen this idea. Indeed, by altering the proper action of key molecules involved in the control of neurotransmitter release and re-cycling as well as synaptic and structural plasticity, α-synuclein deposition may crucially impair axonal trafficking, resulting in a series of noxious events, whose pressure may inevitably degenerate into neuronal damage and death. Here, we provide a timely overview of the molecular features of synaptic loss in PD and disclose their possible translation into clinical symptoms through functional disconnection.

KW - Axonal damage

KW - Functional connectome

KW - Parkinson's disease

KW - Synaptic loss

KW - α-synuclein

UR - http://www.scopus.com/inward/record.url?scp=84959240232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959240232&partnerID=8YFLogxK

U2 - 10.1111/nan.12297

DO - 10.1111/nan.12297

M3 - Article

VL - 42

SP - 77

EP - 94

JO - Neuropathology and Applied Neurobiology

JF - Neuropathology and Applied Neurobiology

SN - 0305-1846

IS - 1

ER -